Delayed-type hypersensitivity skin reaction to Covid-19 vaccine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34934701.
- Also identified by DOI 10.4103/jfmpc.jfmpc_361_21 and PMC identifier 8653437.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Delayed-Type Hypersensitivity Skin Reaction following the Moderna mRNA COVID-19 Vaccine. This case is an unusually prolonged presentation of skin rash following vaccination for the novel COVID-19 virus. This case is clinically significant as it highlights an uncommon but not contraindicated potential side effect and details appropriate medical management. This case highlights that while potentially distressing patients who experience this side effect should be offered reassurance and conservative treatment.